DEA Proposes Massive Increase In Production Of Marijuana & Psilocybin, Amazon Will Hire Weed Smokers
The Drug Enforcement Administration (DEA) is proposing a massive increase in the production of marijuana and psilocybin for research purposes, with the intent of aiding in the development of new federally approved therapeutic medications.
In a notice set to be published in the Federal Register on Thursday, DEA said it is proposing “significant increases” in the manufacturing of “the schedule I substances psilocybin, psilocin, marihuana, and marihuana extract, which are directly related to increased interest by DEA registrants in the use of hallucinogenic controlled substances for research and clinical trial purposes.”
Several national marijuana trade organizations and activist groups submitted written comments about a draft of the most recent federal marijuana reform measure, highlighting the need for lower taxes and interstate commerce.
The formal comments, which were due to the U.S. Senate this week, offer 169 pages of feedback on the Cannabis Administration and Opportunity Act that’s being spearheaded by Senate Majority Leader Charles Schumer and Democratic Sens. Cory Booker and Ron Wyden.
The U.S. Forest Service published a post on cleaning up illegal marijuana grow sites.
On U.S. Forest Service land in California alone, more than 400 illegal grow sites have been identified. This is in part because international drug organizations have traditionally set up illegal grow sites on national forests in California.”
On the eve of Wednesday, September 1, the Cannabis Control Commission (Commission)’s fourth birthday, adult-use Marijuana Establishments in Massachusetts surpassed $2 billion in gross sales, according to information reported in the state’s mandatory seed-to-sale tracking system, the agency announced today.
The newly inaugurated governor of New York says she wants to “jumpstart” the implementation of marijuana legalization—and she took a major step on Wednesday by making two key regulatory appointments to oversee the state’s cannabis market that were quickly confirmed by the Senate during a special session.
Former New York Assemblywoman Tremaine Wright (D) will serve as chair the Cannabis Control Board, and former Drug Policy Alliance (DPA) staffer Christopher Alexander will be the executive director of the state’s Office of Cannabis Management.
California Gov. Gavin Newsom (D) signed a bill to exempt marijuana that is grown under a Drug Enforcement Administration research production license from state regulations. Separately, the state’s top cannabis regulator spoke about efforts to consolidate rulemaking and oversight.
Nikki Fried Had Financial Interest in Marijuana Company While Making Decisions Related to Marijuana Industry
Documents filed in 2020 shows that Nikki Fried had a financial interest in a marijuana company doing business in Florida in 2019, the same year she created the Cannabis Office and the Medical Marijuana Advisory Committee in the Florida Department of Agriculture and Consumer Affairs.
Fried filed her 2019 Form 6 – Full and Public Disclosure of Financial Interests – as required by law on June 30, 2020. The form indicated she had a financial interest in Harvest Health & Recreation through an asset labeled “Ignite Holdings, LLC”. The exact date that the marijuana-related asset was obtained was not provided. The asset was listed with a value of approximately $190,000.
South Dakota lawmakers looking to remake the state’s voter-passed medical marijuana law previewed a coming battle in the Legislature Wednesday as they recommended outlawing growing medical marijuana in homes and allowing local governments to prohibit dispensaries.
A legislative subcommittee approved a spate of recommended changes to a ballot measure voters approved by 70% of voters last year. The law is set to take full effect in the coming months as the state government faces deadlines to issue medical marijuana identification cards and provide for the licensure of medical marijuana dispensaries.
Medical cannabis (MC) use results in long-term reduction of migraine frequency and is associated with less disability and lower antimigraine medication intake, according to a study published in Brain Sciences.
Neither Ontario nor Alberta — far and away, the leaders for the number of cannabis stores in the country — have witnessed a significant rise in emergency visits from traffic-related injuries since weed got the green light three years ago.
“Implementation of the Cannabis Act was not associated with evidence of significant post-legalization changes in the traffic-injury emergency department (ED) visits in Ontario or Alberta among all drivers or youth drivers, in particular,” notes the new Canadian study in Drug and Alcohol Dependence.
Amazon has a solution for a potentially crippling shortage of delivery drivers: Recruit pot smokers.
The company is advising its delivery partners — the mom and pops that operate the vans— to prominently advertise that they don’t screen applicants for marijuana use.